Canopy Growth Corp vs ArcelorMittal SA — how do they compare? Canopy Growth Corp trades at $0.96 (market cap $398.46M), while ArcelorMittal SA trades at $66.94 (market cap $50.59B). The key difference: ArcelorMittal SA is far larger — about 127× Canopy Growth Corp's market cap, and ArcelorMittal SA pays a 0.9% dividend while Canopy Growth Corp pays none. Which is the better fit depends on your goals.
| CGC | MT | |
|---|---|---|
Market Cap | $398.46M | $50.59B |
Sector | Health | Basic Materials |
52-Week High | $1.92 | $71.65 |
52-Week Low | $0.86 | $30.39 |
Enterprise Value | $337.90M | $59.91B |
Dividend Yield | — | 0.9% |
Signals from Pluang's Aura AI — not financial advice
Canopy Growth (CGC) trades at $0.96, down 1.15% on the day, with a mixed technical picture showing a bullish overall signal but bearish moving averages. The company reported a net loss of $598.12 million in 2025, with revenue declining to $269 million, though recent quarterly earnings showed one beat and two misses against expectations. Cash flow remains negative, but the balance sheet shows improving debt-to-asset ratios, down to 33.13% in 2025 from 53.61% in 2023.
The outlook is cautious; while cost-cutting and restructuring efforts are underway, profitability remains elusive, and the stock faces risks including potential delisting due to low share price. Analyst sentiment is divided, with 33% recommending buy, 41% hold, and 26% sell. Investors should weigh the potential for a turnaround against significant operational and regulatory challenges in the cannabis sector.
ArcelorMittal (MT) trades at $65.92, down 0.24% today, with a bullish technical outlook and strong recent earnings beats. The stock shows robust fundamentals with a P/E of 17.26 and P/S of 0.81, supported by a net income margin of 4.71% and consistent dividend payments. Recent news highlights expansion initiatives and a strategic AI collaboration with AWS, driving positive sentiment amid a 41% six-month gain (Zacks Investment Research, 2026-06-23).
Outlook remains positive with analyst consensus at 50% buy ratings, though risks include cyclical steel demand and high capital expenditure. The stock's valuation appears reasonable, but investors should monitor global economic conditions and steel pricing trends for sustained growth.
Trailing returns across standard periods
Canopy Growth, headquartered in Smiths Falls, Canada, cultivates and sells medicinal and recreational cannabis, and hemp, through a portfolio of brands that include Tweed, Spectrum Therapeutics, and CraftGrow. Although it primarily operates in Canada, Canopy has distribution and production licenses in more than a dozen countries to drive expansion in global medical cannabis and also holds an option to acquire Acreage Holdings upon U.S. federal cannabis legalization.
Read more on CGC →ArcelorMittal SA is involved in the steel industry. The company's operating segments include NAFTA
Read more on MT →